SCIENTURE Announces Commercial Launch and Fulfillment of Initial Purchase Orders of REZENOPY™, the Highest Dose FDA-Approved Naloxone Nasal Spray
Globe Newswire•12/08/2026•08:05 ET
0
Whiz Insights
Get started
Create a free account to read the full story.